The AVF is proud to welcome Mark Iafrati, MD as its new President. A highly respected vascular surgeon and long-standing contributor to the venous and lymphatic field, Dr Iafrati brings a wealth of clinical expertise, academic leadership, and a deep commitment to advancing patient care.

Dr Iafrati has built a distinguished career grounded in both academic medicine and clinical innovation. Over the years, he has held key leadership roles within major academic institutions, where he has contributed to the training of future vascular specialists and the advancement of evidence-based venous care. His work has spanned complex venous disease management, clinical research, and multidisciplinary collaboration—areas that continue to shape the evolving landscape of venous and lymphatic medicine.

Now based at Vanderbilt University Medical Center in Tennessee, D. Iafrati is actively engaged in delivering high-quality, patient-centered care while remaining closely connected to national and international efforts to improve outcomes in venous disease. His current work reflects a balance of clinical excellence and strategic vision, with a focus on expanding access to care, integrating new technologies, and fostering collaboration across specialties.

A dedicated member of AVF for many years, Dr Iafrati has contributed extensively through committee leadership, educational programming, and mentorship initiatives. His longstanding involvement has helped strengthen the organization’s mission to improve care for patients with venous and lymphatic disease through education, research, and advocacy.

As President, Dr Iafrati is poised to guide AVF into its next phase of growth—building on its strong foundation while embracing innovation and global engagement. His leadership will continue to elevate AVF’s role as a leading voice in venous and lymphatic health. Dr Iafrati’s inaugural address outlined his vision for the upcoming year. It focused on themes of inclusivity, AVF’s core mission of research, and the importance of balancing both the scientific and clinical perspectives as the organization works to advance care for patients with venous and lymphatic disease.

The AVF community looks forward to the impact of Dr Iafrati’s presidency and the continued advancement of the field under his guidance.